Table of contents

Inflammatory bowel disease

• Paper: Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production (22 October, 2010)

  Peter J Mannon, Ronald L Hornung, Zhiqiong Yang, Chuli Yi, Catherine Groden, Julia Friend, Michael Yao, Warren Strober, Ivan J Fuss
• Paper: H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy (26 January, 2011) Free

  Jean-François Rahier, Pavol Papay, Julia Salleron, Shaji Sebastian, Manuela Marzo, Laurent Peyrin-Biroulet, Valle Garcia-Sanchez, Walter Fries, Dirk P van Asseldonk, Klaudia Farkas, Nanne K de Boer, Taina Sipponen, Pierre Ellul, Edouard Louis, Simon T C Peake, Uri Kopylov, Jochen Maul, Badira Makhoul, Gionata Fiorino, Yazdan Yazdanpanah, Maria Chaparro, for the European Crohn's and Colitis Organisation (ECCO)
• Paper: Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease (17 January, 2011)

  Raffaella M Gadaleta, Karel J van Erpecum, Bas Oldenburg, Ellen C L Willemsen, Willem Renooij, Stefania Murzilli, Leo W J Klomp, Peter D Siersema, Marguerite E I Schipper, Silvio Danese, Giuseppe Penna, Gilles Laverny, Luciano Adorini, Antonio Moschetta, Saskia W C van Mil